Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Taysha Gene Therapies
TSHA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.15
-0.04
-1.83%
At Close: -
$2.13
-0.02
-0.92%
After Hours: 7:33 PM EDT
15 minutes delayed
Get Report
Comment
Taysha Gene Therapies (TSHA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Taysha Gene Therapies (NASDAQ:TSHA) Stock
Taysha Gene Therapies Stock (NASDAQ: TSHA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, August 14, 2024
Canaccord Genuity Maintains Buy on Taysha Gen...
Benzinga Newsdesk
Tuesday, August 13, 2024
Chardan Capital Maintains Buy on Taysha Gene ...
Benzinga Newsdesk
Monday, August 12, 2024
Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights
Benzinga Insights
Needham Maintains Buy on Taysha Gene Therapie...
Benzinga Newsdesk
Taysha Gene Therapies Q2 2024 GAAP EPS $(0.09...
Benzinga Newsdesk
Friday, July 26, 2024
Needham Reiterates Buy on Taysha Gene Therapi...
Benzinga Newsdesk
Tuesday, July 23, 2024
Where Taysha Gene Therapies Stands With Analysts
Benzinga Insights
Needham Reiterates Buy on Taysha Gene Therapi...
Benzinga Newsdesk
Monday, July 01, 2024
Piper Sandler Maintains Overweight on Taysha ...
Benzinga Newsdesk
Thursday, June 27, 2024
BMO Capital Initiates Coverage On Taysha Gene...
Benzinga Newsdesk
Wednesday, June 26, 2024
Taysha Gene Therapies Announces Pricing Of ~$...
Benzinga Newsdesk
Taysha Gene Therapies shares are trading lowe...
Benzinga Newsdesk
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Taysha Gene Therapies Disclosed That It Has C...
Benzinga Newsdesk
Thursday, June 20, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Wednesday, June 19, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Needham Reiterates Buy on Taysha Gene Therapi...
Benzinga Newsdesk
Tuesday, June 18, 2024
Chardan Capital Maintains Buy on Taysha Gene ...
Benzinga Newsdesk
S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings
Avi Kapoor
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Crude Oil Rises 1%; DermTech Shares Plummet
Avi Kapoor
What's Going On With Taysha Gene Therapies Stock Tuesday?
Vandana Singh
Taysha Gene Therapies shares are trading lowe...
Benzinga Newsdesk
Taysha Gene Therapies Shares Halted To The Do...
Benzinga Newsdesk
Taysha Gene Therapies Announced Longer-term C...
Benzinga Newsdesk
Monday, June 17, 2024
The Analyst Landscape: 16 Takes On Taysha Gene Therapies
Benzinga Insights
Needham Reiterates Buy on Taysha Gene Therapi...
Benzinga Newsdesk
Wednesday, June 12, 2024
Taysha Gene Therapies Disclosed That It Will ...
Benzinga Newsdesk
Tuesday, May 28, 2024
Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Wednesday, May 15, 2024
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Needham Reiterates Buy on Taysha Gene Therapi...
Benzinga Newsdesk
Tuesday, May 14, 2024
Taysha Gene Therapies Q1 EPS $(0.10) Beats $(...
Benzinga Newsdesk
Jefferies Assumes Taysha Gene Therapies at Bu...
Benzinga Newsdesk
Thursday, May 02, 2024
Needham Reiterates Buy on Taysha Gene Therapi...
Benzinga Newsdesk
Taysha Gene Therapies Announces Regenerative ...
Benzinga Newsdesk
Tuesday, April 30, 2024
11 Analysts Assess Taysha Gene Therapies: What You Need To Know
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Friday, April 19, 2024
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Thursday, April 18, 2024
Cantor Fitzgerald Reiterates Overweight on Ta...
Benzinga Newsdesk
Friday, April 12, 2024
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Thursday, April 11, 2024
Needham Reiterates Buy on Taysha Gene Therapi...
Benzinga Newsdesk
Wednesday, April 10, 2024
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Tuesday, April 09, 2024
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts
Benzinga Insights
Taysha Gene Therapies shares are trading high...
Benzinga Newsdesk
Piper Sandler Initiates Coverage On Taysha Ge...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch